Ortokine therapy

سال انتشار: 1397
نوع سند: مقاله کنفرانسی
زبان: انگلیسی
مشاهده: 374

نسخه کامل این مقاله ارائه نشده است و در دسترس نمی باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

APAMED08_033

تاریخ نمایه سازی: 23 آذر 1397

چکیده مقاله:

Orthokine® (autologous conditioned serum or ACS) is a special serum from the patients own blood, which features a significantly higher concentration of signaling proteins, especially Interleukin-1 receptor antagonist (IL-1Ra) and different growth factors.The initial idea to develop the Orthokine®-therapy is based on the fact that Interleukin-1(IL-1; a messenger of the immune system) plays an important role in cartilage degradation, nerve root inflammation and pain.The opponent of IL-1, IL-1Ra, is a natural inhibitor of IL-1. Particular immune cells in the blood of a patient are capable of releasing IL-1Ra in large quantities. During the processingof Orthokine those cells are triggered to do so as well as several growth factors, which play an important role in connective tissue repair.

نویسندگان

Behram Naderi Nabi

MD, Anesthesiologist, pain fellowship